The ongoing battle between Sun Pharma and Taro Pharma is intensifying once again, as Mark Mobius, an investor in Taro through Franklin Templeton, wants Sun Pharma to pay two and half times more for the buyout. Mobius is asking for $20 per share as against the original offer of $7.75 per share.